HaraldssonB., NystromJ., DeenW.M.Properties of the Glomerular Barrier and Mechanisms of Proteinuria. Physiol Rev2008; 88: 451–87.
2.
CirilloM.Evaluation of glomerular filtration rate and of albuminuria/proteinuria. J Nephrol2010; 23: 125–32.
3.
KnollG.A.Proteinuria in Kidney Transplant Recipients: Prevalence, Prognosis, and Evidence-Based Management. Am J Kidney Dis2009; 54: 1131–44.
4.
SanchoA., GavelaE., AvilaA.. Risk factors and pro-gnosis for proteinuria in renal transplant recipients. Transplant Proc2007; 39: 2145–7.
5.
HalimiJ.M., LaouadI., BuchlerM.. Early low grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant2005; 5: 2281–8.
6.
AmerH., FidlerM.E., MyslakM.. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant2007; 7: 2748–56.
7.
HalimiJ., LaouadI., BuchlerM.. Early proteinuria is a strong indicator of donor renal lesions, ischemia-reperfusion injury and immunological aggression. Transplant Proc2006; 38: 2319–20.
8.
FirstM.R., VaidyaP.N., MaryniakR.K.. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation1984; 38: 607–12.
SarafidisP.A., BakrisG.L.Renin-angiotensin blockade and kidney disease. Lancet.2008; 372: 511–2.
12.
BakrisG.L.Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol2008; 3(Suppl 1): S3–10.
13.
HiremathS., FergussonD., DoucetteS.. Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence. Am J Transplant2007; 7: 2350–60.
14.
HeinzeG., MitterbauerC., RegeleH.. Angiotensin Converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol2006; 17: 889–99.
15.
OpelzG., ZeierM., LauG.. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A Collaborative Transplant Study Report. J Am Soc Nephrol2006; 17: 3257–62.
16.
MyslakM., AmerH., MoralesP.. Interpretino post-transplant proteinuria in patients with proteinuria pretransplant. Am J Transplant2006; 6: 1660–5.
17.
BianconeL., BussolatiB., MazzuccoG.. Loss of nephrin expression in glomeruli of kidney-transplanted patients under mTOR inhibitor therapy. Am J Transplant2010; 10: 2270–8.
18.
FranzS., RegeniterA., HopferH.. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial. Am J Kidney Dis2010; 55: 335–43. Epub 2009 Nov 17.
19.
SchenaF.P.Review of symposium. Sirolimus in kidney transplantation. Transplantation. 2009;27; 87(Suppl 8): S30–3.
